R&S Holdings, Inc. expands its healthcare footprint through the acquisition of Pennsylvania-based substance use disorder treatment provider Innovo Detox, facilitated by M&A Healthcare Advisors.
Innovo Detox, a Pennsylvania-based substance use disorder treatment provider, is being sold to R&S Holdings, Inc. with no financial terms disclosed.
R&S Holdings, Inc. is acquiring Innovo Detox, a substance use disorder treatment provider, as announced in the press release.
R&S Holdings, Inc. has completed the acquisition of Innovo Detox, a Pennsylvania-based provider specializing in substance use disorder treatment. M&A Healthcare Advisors served as the investment bank for the transaction, though the specific financial terms of the deal remain undisclosed.
Innovo Detox was acquired by R&S Holdings, Inc.
Innovo Detox is a Pennsylvania-based provider of substance use disorder (SUD) treatment services.